
CellmatiQ leverages artificial intelligence to enhance medical image analytics, focusing on dental and ophthalmic diagnostics. Their flagship product, DentaliQ, automates cephalometric analysis, significantly reducing the time required for image evaluation while maintaining high accuracy. The company offers a range of AI-driven modules for various diagnostic needs, including caries detection and glaucoma indication. With a cloud-ready AI-as-a-Service model, CellmatiQ positions itself as a leader in the healthcare AI space, recognized in multiple startup rankings and certifications, including MDD for their medical devices.

CellmatiQ leverages artificial intelligence to enhance medical image analytics, focusing on dental and ophthalmic diagnostics. Their flagship product, DentaliQ, automates cephalometric analysis, significantly reducing the time required for image evaluation while maintaining high accuracy. The company offers a range of AI-driven modules for various diagnostic needs, including caries detection and glaucoma indication. With a cloud-ready AI-as-a-Service model, CellmatiQ positions itself as a leader in the healthcare AI space, recognized in multiple startup rankings and certifications, including MDD for their medical devices.
Location: Hamburg, Germany
Founded: 2018 (Feb)
Core product: DentaliQ — AI-driven dental image analysis (cephalometric automation)
Regulatory: First product has MDD (EU/CE) medical device certification
Known funding: Seed/Angel round (Jan 2019); investor: IFB Innovationsstarter
Medical image analytics for dental and ophthalmic diagnostics.
2018
Healthcare AI; Medical devices